Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Value of Incorporating Newly Identified Risk Factors into Risk Prediction for Chemotherapy-Induced Febrile Neutropenia (FN)

Yanli Li, MD PhD, Leila Family, PhD, Lie Hong Chen, DrPH, John H. Page, MD ScD, Zandra K. Klippel, MD, Lanfang Xu, PhD, Chun Chao, PhD

Blood (2016) 128 (22): 4797.

https://doi.org/10.1182/blood.V128.22.4797.4797

Published: 2016

Journal Articles

Risk of Febrile Neutropenia (FN) in Select Myelosuppressive Chemotherapy Regimens

Leila Family, PhD, Su-Jau Yang, Zandra Klippel, MD, Yanli Li, MD PhD, John H Page, MD ScD, Roberto Rodriguez, MD, Chun Chao, PhD

Blood (2015) 126 (23): 3257.

https://doi.org/10.1182/blood.V126.23.3257.3257

Published: 2015

Journal Articles

The Impact of Primary Prophylaxis with Granulocyte Colony-Stimulating Factors on Febrile Neutropenia during Chemotherapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Li Wang, PhD, Onur Baser, PhD, Lucie Kutikova, PhD, John H Page, MD ScD, Richard L Barron, MS

Blood (2014) 124 (21): 4850.

https://doi.org/10.1182/blood.V124.21.4850.4850

Published: 2014

Journal Articles

Relationship Between Severity and Duration of Chemotherapy Induced Neutropenia and Risk of Infection Among Patients with Non-Myeloid Malignancies

Yanli Li, MDPhD, Xiaolong Shih, PhD, Zandra K. Klippel, MD, Maureen Reiner, M.S., John H Page, MD ScD

Blood (2014) 124 (21): 4960.

https://doi.org/10.1182/blood.V124.21.4960.4960

Published: 2014

Journal Articles

Incidence of Chemotherapy Induced Anemia in Patients Diagnosed with Solid Tumors

Hairong Xu, MD, PhD, Lanfang Xu, MS, John H Page, MD ScD, Olivia Sattayapiwat, MS, Roberto Rodriguez, MD, Chun Chao, PhD

Blood (2014) 124 (21): 4822.

https://doi.org/10.1182/blood.V124.21.4822.4822

Published: 2014

Journal Articles

Trends in Anemia Treatment Among Patients with Non-Myeloid Malignancies Treated with Chemotherapy

Chun Chao, PhD, Lanfang Xu, MS, Olivia Sattayapiwat, MS, John H Page, MD ScD, Kimberly Cannavale, Roberto Rodriguez, MD, Chet Bohac, Hairong Xu, MD, PhD

Blood (2014) 124 (21): 6007.

https://doi.org/10.1182/blood.V124.21.6007.6007

Published: 2014

Journal Articles

Timing of Primary Prophylaxis G-CSF Use during Chemotherapy in Elderly Patients with NHL

Shuling Li, PhD, Iberia Romina Sosa, MD PhD, Julia T Molony, MS, John H Page, MD ScD, Richard L Barron, MS, Jiannong Liu, PhD, Phuong Khanh Morrow, MD, Scott Stryker, MD DrPH, John F Acquavella, PhD, Allan J Collins, MD FACP

Blood (2014) 124 (21): 6013.

https://doi.org/10.1182/blood.V124.21.6013.6013

Published: 2014

Journal Articles

Oral Antimicrobial Drug Use during Chemotherapy in Medicare Enrollees with NHL

Julia T Molony, MS, Iberia Romina Sosa, MD PhD, Shuling Li, PhD, John H Page, MD ScD, Richard L Barron, MS, Jiannong Liu, PhD, Phuong Khanh Morrow, MD, Scott Stryker, MD DrPH, John F Acquavella, PhD, Allan J Collins, MD FACP

Blood (2014) 124 (21): 6022.

https://doi.org/10.1182/blood.V124.21.6022.6022

Published: 2014

Journal Articles

Risk Factors For Bone Pain Among Patients Receiving Myelosuppressive Chemotherapy and Primary Prophylactic Pegfilgrastim

Hairong Xu, M.D., Ph.D., Qi Gong, Florian D Vogl, Esteban Abella, MD, John H Page, MD, ScD

Blood (2013) 122 (21): 1710.

https://doi.org/10.1182/blood.V122.21.1710.1710

Published: 2013

Journal Articles

Use Of Pegfilgrastim Primary Prophylaxis By Chemotherapy Cycle Among Patients With Non-Hodgkin’s Lymphoma Or Breast Cancer

Wendy J Langeberg, PhD, MPH, Conchitina C Siozon, MS, PK Morrow, MD, John H Page, MD, ScD, Victoria M Chia, PhD, MPH

Blood (2013) 122 (21): 5598.

https://doi.org/10.1182/blood.V122.21.5598.5598

Published: 2013

Journal Articles

Chronic Comorbidities and Chemotherapy-Induced Febrile Neutropenia in Patients with Non-Hodgkin Lymphoma

Chun Chao, PhD, John H Page, MD, ScD, Roberto Rodriguez, MD, Su-Jau Yang, PhD, Julie Huynh, MD, Victoria M Chia, PhD

Blood (2012) 120 (21): 3671.

https://doi.org/10.1182/blood.V120.21.3671.3671

Published: 2012

Journal Articles

Patterns of Granulocyte Colony-Stimulating Factor (G-CSF) Use in Elderly Patients with Non-Hodgkin's Lymphoma (NHL) Receiving Myelosuppressive Chemotherapy

John H Page, MD, ScD, Craig Solid, PhD, Victoria M Chia, PhD, Anne Hudson Blaes, MD, Richard L. Barron, Mi Rim Choi, MD, Thomas J Arneson, MD, MPH

Blood (2012) 120 (21): 5078.

https://doi.org/10.1182/blood.V120.21.5078.5078

Published: 2012

NARROW

Value of Incorporating Newly Identified Risk Factors into Risk Prediction for Chemotherapy-Induced Febrile Neutropenia (FN)

Risk of Febrile Neutropenia (FN) in Select Myelosuppressive Chemotherapy Regimens

The Impact of Primary Prophylaxis with Granulocyte Colony-Stimulating Factors on Febrile Neutropenia during Chemotherapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Relationship Between Severity and Duration of Chemotherapy Induced Neutropenia and Risk of Infection Among Patients with Non-Myeloid Malignancies

Incidence of Chemotherapy Induced Anemia in Patients Diagnosed with Solid Tumors

Trends in Anemia Treatment Among Patients with Non-Myeloid Malignancies Treated with Chemotherapy

Timing of Primary Prophylaxis G-CSF Use during Chemotherapy in Elderly Patients with NHL

Oral Antimicrobial Drug Use during Chemotherapy in Medicare Enrollees with NHL

Risk Factors For Bone Pain Among Patients Receiving Myelosuppressive Chemotherapy and Primary Prophylactic Pegfilgrastim

Use Of Pegfilgrastim Primary Prophylaxis By Chemotherapy Cycle Among Patients With Non-Hodgkin’s Lymphoma Or Breast Cancer

Chronic Comorbidities and Chemotherapy-Induced Febrile Neutropenia in Patients with Non-Hodgkin Lymphoma

Patterns of Granulocyte Colony-Stimulating Factor (G-CSF) Use in Elderly Patients with Non-Hodgkin's Lymphoma (NHL) Receiving Myelosuppressive Chemotherapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only